Zevalin helps lymphoma patient in Idaho to recover

10/18/2010 | KIFI-TV (Idaho Falls)

John Wolfe, a patient with lymphoma mantle cell B, is the first one in Portneuf Medical Center and in the southeastern Idaho area to be treated with Zevalin, a drug that accurately zeroes in and tags cancer cells. Doctors at the medical center said months of treatment with the drug has allowed Wolfe to begin recovering. The center is thinking about using the drug to treat more patients.

View Full Article in:

KIFI-TV (Idaho Falls)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC